Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F

Gauzy Ltd. (NASDAQ: GAUZ) said Nasdaq notified it on May 19, 2026 that it is not compliant with Nasdaq Rule 5250(c)(1) due to a delayed filing of its 2025 Form 20-F. Nasdaq said the notice has no immediate impact on trading, but the company will be listed as non-compliant. Gauzy has 60 days (until July 20, 2026) to submit a plan.

Original reporting
Published May 26, 2026, 3:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 4:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F — source image
Decision brief

The 30-second read

$GAUZBearishHigh
01

Why it matters

The key trading variable becomes whether Nasdaq accepts a remediation plan and whether the 20-F is filed within any granted cure/exception window; failure increases delisting risk.

02

Market read

A compliance notice tied to SEC reporting timeliness can quickly reprice delisting risk and liquidity for GAUZ.

03

What to watch

Market may focus more on the separate minimum bid price non-compliance and the company’s ability to secure funding/complete filings, which could dominate the stock’s reaction.

Relevance 9/10Timing: 60-day plan deadline (July 20, 2026) with potential up to 180-day extension if accepted.

Background

Nasdaq issued a second notice: delayed 2025 Form 20-F filing (Rule 5250(c)(1)) on top of prior minimum bid price non-compliance.

Company-level read

Ticker impact

$GAUZBearishHigh confidence
Context

Gauzy received a Nasdaq notice for delayed filing of its 2025 Form 20-F, risking continued listing and potential delisting.

Expected impact

Near-term downside bias and higher volatility as investors price in compliance-plan odds and reporting delays.

Evidence & confidence

The company is explicitly flagged for Nasdaq Rule 5250(c)(1) due to a delayed 20-F, with delisting risk if it fails to regain compliance by the stated deadlines.

Market effects

Raises risk premium for other small-cap issuers with late SEC filings and Nasdaq compliance exposure.

Israel-domiciled Nasdaq listings may see investor scrutiny on disclosure timeliness.

Limited direct global read-across; primarily a US listing/compliance event.

Counterpoint

The notice states no immediate effect on trading and the company intends to submit a compliance plan, which can reduce worst-case delisting probability.

Key entities

  • Gauzy Ltd.

    Nasdaq-listed company receiving the delayed 20-F non-compliance notice and required to submit a compliance plan.

  • Nasdaq Listing Qualifications Department

    The Nasdaq unit that issued the notice under Listing Rule 5250(c)(1).

  • The Nasdaq Stock Market LLC

    The exchange whose listing rules govern compliance and potential delisting outcomes.

  • SEC

    The SEC receives the Form 20-F; the delay is the trigger for Nasdaq non-compliance.

Related articles

$GAUZMed

GAUZY LTD: Gauzy Announces Court-Approved Resolution of Legacy Debt Following Overwhelming 98.96% Creditor Vote, Including 100% of Secured Lenders

Gauzy Ltd. (NASDAQ: GAUZ) announced a court-approved debt settlement resolving $61M in legacy liabilities, with 98.96% creditor approval. The company secured $7M in new equity capital and will make monthly payments over six years. The settlement lifts insolvency stay and resolves legal proceedings.

$GAUZMedAI 8/10

Smart glass co Gauzy seeks debt settlement

Gauzy (Nasdaq: GAUZ) reported to investors and creditors on a proposed debt settlement after former employees sought insolvency proceedings. The plan includes a $7 million PIPE and two repayment options: an exit event generating over $330 million to repay all debts, or paying 25% of GAAP net profit annually until repaid. Gauzy has not filed since Q2 2025.

$NVDAHigh

The US let Nvidia sell chips to an empty office in China

The US has approved Nvidia's sales of AI chips to Chinese firms linked to blacklisted entities, according to reports. The approvals are for companies with no current use for the chips, raising questions about the policy's intent. Nvidia's H800 chip, a less powerful version of its AI chips, is among those approved for sale. The approvals come as the US seeks to limit China's access to advanced technology.

$GOOGMed

Google, Meta, and TikTok Sue California Over AB 1709 Ban on Addictive Feeds for Children Under 16

Google, Meta, and TikTok sued California over AB 1709, a law restricting addictive social media features for children under 16. The companies argue it violates the First Amendment and conflicts with Section 230. The law targets personalized feeds, endless scrolling, and autoplay videos, requiring age verification. The state aims to protect children from exploitative features. The lawsuits are being reviewed by California's Attorney General. The law is set to take effect in 2027.

$DGXLow

Quest Diagnostics pays $13M to settle kickback allegations involving NY Giants tickets

Quest Diagnostics agreed to pay $13M to settle allegations of providing illegal kickbacks, including NY Giants tickets, to healthcare providers for referrals, according to the U.S. Attorney’s Office of New Jersey. The settlement resolves claims of violating the Anti-Kickback Statute and submitting false claims to Medicare and Medicaid. Quest denies wrongdoing but agreed to the settlement to resolve the matter.